학술논문
1506TiPPhase I study of the AXL inhibitor DS-1205c in combination with osimertinib in subjects with metastatic or unresectable EGFR-mutant NSCLC.
Document Type
Article
Author
Source
Subject
*EPIDERMAL growth factor receptors
*NON-small-cell lung carcinoma
*
Language
ISSN
0923-7534